Welcome to our dedicated page for Blackstone SEC filings (Ticker: BX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Blackstone Inc. filings document the public-company disclosures of an alternative asset manager with common stock listed on the New York Stock Exchange under BX. The filing record includes 8-K reports for quarterly and annual results, earnings presentations, dividend declarations, realization updates and Regulation FD disclosures tied to Blackstone’s investment-management economics.
Blackstone’s SEC filings also cover capital-structure activity, including senior note offerings by Blackstone Reg Finance Co. L.L.C., guarantees by Blackstone and related holding entities, supplemental indentures, shelf registration use, exhibits and amendments to furnished earnings materials. These documents record formal disclosures on financial condition, material agreements, securities issuance, guarantor structure and recurring public-company reporting obligations.
Blackstone Inc. director Joseph Baratta reported an estate-planning gift involving Blackstone Holdings Partnership Units. Interests in a limited liability company associated with him were gifted to a family trust, representing 41,290 Blackstone Holdings Partnership Units, in a bona fide gift transaction at a price of $0 per unit.
The limited liability company continues to hold 4,128,950 Blackstone Holdings Partnership Units, while additional units are held directly and through a family trust. Each partnership unit is exchangeable, subject to partnership agreement conditions, for one share of Blackstone Inc. common stock, and the units have no expiration date.
Blackstone Inc. furnished an update on its performance by announcing financial results for the fourth quarter and full year 2025. The company did this through a press release and detailed presentation dated January 29, 2026, which are referenced in this report.
The press release is included as Exhibit 99.1 and is treated as furnished rather than filed under securities rules. The report is authorized on behalf of Blackstone by its Chief Financial Officer, Michael S. Chae.
Blackstone Inc. Chief Accounting Officer David Payne reported receiving a grant of 1,656 shares of common stock on January 12, 2026 at a price of $0 per share. These are deferred restricted shares granted under the Amended and Restated 2007 Equity Incentive Plan.
The award will vest in three equal installments of 552 shares on January 1, 2027, January 1, 2028, and January 1, 2029, subject to Payne’s continued employment with Blackstone. As the deferred restricted shares vest, the underlying shares will be delivered to him, with the possibility of earlier delivery if there is a change in control of Blackstone. Following this grant, Payne beneficially owns 56,144 shares of Blackstone common stock directly.
Blackstone Inc.'s Chief Administrative Officer, Vikrant Sawhney, reported an equity compensation grant. On January 12, 2026, he received 29,458 shares of common stock at a price of $0, granted under the Amended and Restated 2007 Equity Incentive Plan as deferred restricted shares. These shares will vest over three years, with 9,820 shares vesting on January 1, 2027, 9,819 shares on January 1, 2028, and 9,819 shares on January 1, 2029, subject to his continued employment, and may be delivered earlier upon a change in control of Blackstone. Following this grant, he beneficially owned 766,706 shares directly, and an additional 51,500 shares are held indirectly in a grantor retained annuity trust for which he serves as investment trustee.
Blackstone Inc.’s Chief Legal Officer, Finley John G, reported an award of 14,959 shares of common stock on January 12, 2026 at a price of $0 per share. These are deferred restricted shares granted under the Amended and Restated 2007 Equity Incentive Plan and will vest over three years, with 4,987 shares vesting on January 1, 2027, 4,986 shares on January 1, 2028, and 4,986 shares on January 1, 2029, subject to his continued employment.
After this grant, Finley directly holds 468,795 shares of Blackstone common stock. Additional indirect holdings are reported through related entities, including a limited liability company and several family trusts, which together hold 22,523, 11,000, 2,000 and 2,000 shares respectively. The filing notes that he disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.
Blackstone Inc. CFO & Vice Chairman Michael Chae reported an equity award of 41,174 shares of common stock on January 12, 2026. The shares were granted at $0 per share under Blackstone’s Amended and Restated 2007 Equity Incentive Plan and are structured as deferred restricted shares.
These shares vest ratably over three years, with 13,725 shares vesting on January 1, 2027, 13,724 shares on January 1, 2028, and 13,725 shares on January 1, 2029, subject to Chae’s continued employment with Blackstone. As they vest, the underlying shares will be delivered to him, with potential earlier delivery if there is a change in control of Blackstone. Following this grant, Chae beneficially owns 1,015,668 common shares directly.
Blackstone Inc. reported that President & COO and director Jonathan Gray received 51,216 shares of common stock on January 12, 2026. These are deferred restricted shares granted at a price of $0 per share under the Amended and Restated 2007 Equity Incentive Plan, increasing his directly held beneficial ownership to 3,375,755 shares.
The award will vest in three equal installments of 17,072 shares on January 1, 2027, January 1, 2028, and January 1, 2029, as long as Gray remains employed by Blackstone. As each portion vests, the underlying shares will be delivered to him, with potential earlier delivery if there is a change in control of Blackstone.
Blackstone Inc. director Joseph Baratta reported receiving an award of 51,216 shares of common stock on January 12, 2026. These are deferred restricted shares granted under Blackstone’s Amended and Restated 2007 Equity Incentive Plan at a price of $0 per share, reflecting an equity compensation grant rather than an open-market purchase.
The shares vest in three equal installments of 17,072 shares on January 1, 2027, January 1, 2028, and January 1, 2029, as long as Baratta remains employed by Blackstone. As each portion vests, the underlying shares will be delivered to him, with the possibility of earlier delivery if there is a change in control of Blackstone. Following this grant, Baratta beneficially owns 746,973 common shares directly.
Entities affiliated with Blackstone Inc., as 10% owners of Legence Corp. (LGN), reported several related transactions on 01/08/2026. Legence Parent ML LLC exchanged 780,121 Class B Units of Legence Holdings LLC, together with an equal number of Class B Common shares forfeited for no additional consideration, for the same number of Class A Common shares. In connection with underwriters exercising their over-allotment option in a secondary offering, Parent ML and Legence Parent II ML LLC sold Class A Common shares to the underwriters at the public offering price of $45.00 per share, less underwriting discounts and commissions of $1.575 per share. Following these transactions, Parent ML indirectly held 958,692 Class A and 40,699,833 Class B shares, and Parent II ML indirectly held 25,162,794 Class A shares, with higher-tier Blackstone entities and Stephen A. Schwarzman reporting indirect beneficial ownership subject to stated disclaimers.
Blackstone-affiliated reporting persons have filed an initial ownership statement for Medline Inc. (MDLN), showing large indirect stakes and board roles. The filing lists indirect beneficial ownership of 156,649,816 shares of Class A common stock and 11,724 additional Class A shares through Blackstone-managed entities, plus 79,327,072 shares of Class B common stock. The Class B shares carry one vote per share but no economic value and are paired one-for-one with Common Units of Medline Holdings, LP. Under an exchange agreement dated December 16, 2025, these Common Units are exchangeable into an equal number of Medline Class A shares on a one-for-one basis, with exchange rights that do not expire. The reporting persons note that, other than the directly holding partnerships, they disclaim beneficial ownership beyond their pecuniary interests.